학술논문
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG
Document Type
article
Author
Burke, Michael J; Salzer, Wanda L; Devidas, Meenakshi; Dai, Yunfeng; Gore, Lia; Hilden, Joanne M; Larsen, Eric; Rabin, Karen R; Zweidler-McKay, Patrick A; Borowitz, Michael J; Wood, Brent; Heerema, Nyla A; Carroll, Andrew J; Winick, Naomi; Carroll, William L; Raetz, Elizabeth A; Loh, Mignon L; Hunger, Stephen P
Source
Haematologica. 104(5)
Subject
Language
Abstract
With modern chemotherapy, approximately 90% of patients with pediatric acute lymphoblastic leukemia are now cured. However, subsets of patients can be identified who remain at very high risk of relapse with expected 4-year disease-free survival rates